Home Newsfeeds Rosenblatt Initiates Coverage On Intercontinental Exchange with Buy Rating, Announces Price Target of $164

Rosenblatt Initiates Coverage On Intercontinental Exchange with Buy Rating, Announces Price Target of $164

Rosenblatt analyst Andrew Bond initiates coverage on Intercontinental Exchange (NYSE:ICE) with a Buy rating and announces Price Target of $164.

byBenzinga Newsdesk

August 17, 2022

1 minute read

Rosenblatt analyst Andrew Bond initiates coverage on Intercontinental Exchange (NYSE:ICE) with a Buy rating and announces Price Target of $164.

Morgan Stanley Maintains Overweight on Voya Financial, Raises Price Target to $75

By Benzinga Newsdesk

August 3, 10:18 AM

Morgan Stanley analyst Nigel Dally maintains Voya Financial (NYSE:VOYA) with a Overweight and raises the price target from $73 to $75.

VOYA

Doctor Who Showrunner Russell T. Davies Debunks Fortnite Collab: ‘It’s a Complete Myth’

By Franca Quarneti

February 12, 10:01 PM

Doctor Who's showrunner, Russell T. Davies, has refuted rumors of a collaboration between Doctor Who and Epic Games' Fortnite.

DIS

FIGS Q2 EPS $0.03 Beats $0.02 Estimate, Sales $122.25M Beat $119.73M Estimate

By Bill Haddad

August 4, 6:46 PM

FIGS (NYSE:FIGS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 62.5 percent decrease over earnings of $0.08 per share from the same period last

FIGS

What’s Going On With Clover Health Investments Stock?

By Ryan Gustafson

August 29, 4:17 PM

Clover Health Investments, Corp. (NASDAQ: CLOV) shares are trading higher Tuesday.

CLOV

Rosenblatt Initiates Coverage On Intercontinental Exchange with Buy Rating, Announces Price Target of $164

Related Posts

Morgan Stanley Maintains Overweight on Voya Financial, Raises Price Target to $75

Doctor Who Showrunner Russell T. Davies Debunks Fortnite Collab: ‘It’s a Complete Myth’

FIGS Q2 EPS $0.03 Beats $0.02 Estimate, Sales $122.25M Beat $119.73M Estimate

What’s Going On With Clover Health Investments Stock?